EPO and anemia (phenotype): Even though EPO has been widely applied in preterm infants to prevent anemia, to treat preterm ICH the optimal dose protocol and course as well as the gestational age of the preterm infants need to be investigated further because EPO treatment has shown gestational age-related differences [116, 118, 119].